Atorvastatin Effect on Reduction of COPD Exacerbations

This trial is testing whether atorvastatin (a common cholesterol-lowering drug) can reduce flare-ups of chronic obstructive pulmonary disease (COPD) — a lung condition that causes breathing difficulties. Earlier research suggested statins may have anti-inflammatory effects in the lungs, and this study aims to find out whether that translates into fewer COPD episodes. **You may be eligible if...** - You are 40 years or older - You have a confirmed diagnosis of stable COPD with persistent breathing limitation - You have had at least two COPD exacerbations (flare-ups) in the past year - You are able to follow the study protocol and attend visits **You may NOT be eligible if...** - You are already taking a statin medication - Your COPD is currently unstable or you are in the middle of a flare-up - You have liver or muscle conditions that make statin use unsafe - You are under 40 Talk to your doctor to see if this trial is right for you.